Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss	$ (53,045)	$ (90,616)
Adjustments to reconcile net loss to net cash used in operating activities
Impairment of intangible assets	5,758	69,900
Impairment of long-lived assets	9,727	0
Settlement of Global Cooling escrow	(5,115)	0
Depreciation	5,646	5,056
Amortization of intangible assets	4,266	8,236
Amortization of loan costs	13	0
Stock-based compensation	23,337	17,671
Non-cash lease expense	494	1,025
Deferred income tax expense (benefit)	36	(4,937)
Change in fair value of contingent consideration	(1,778)	(3,348)
Change in fair value of equity investments	0	(697)
Accretion of investments	(1,049)	0
Loss on disposal of property and equipment, net	227	54
Loss on disposal of assets held for rent, net	443	369
Other	0	302
Change in operating assets and liabilities, net of effects of acquisitions
Accounts receivable, trade, net	9,437	(9,438)
Inventories	(8,450)	(5,403)
Prepaid expenses and other assets	(1,045)	(1,843)
Accounts payable	(3,380)	(3,615)
Accrued expenses and other current liabilities	(1,692)	444
Warranty liability	(97)	(1,031)
Sales taxes payable	1,330	1,526
Other	128	0
Net cash used in operating activities	(14,809)	(16,345)
Cash flows from investing activities
Purchases of available-for-sale securities	(22,688)	(35,767)
Proceeds from sale of available-for-sale securities	2,971	0
Maturities of available-for-sale securities	42,450	750
Purchases of assets held for rent	(3,453)	(2,269)
Purchases of property and equipment	(5,400)	(5,937)
Net cash provided by (used in) investing activities	13,880	(43,223)
Cash flows from financing activities
Payments on equipment loans	(383)	(370)
Proceeds from exercise of common stock options	370	307
Proceeds from term loans	0	20,000
Payments on term loans	300	1,750
Fees paid related to issuance of common stock	0	(130)
Proceeds from financed insurance premium	2,639
Payments on financed insurance premium	(1,653)	(814)
Other	77	(302)
Net cash provided by financing activities	750	16,941
Net decrease in cash, cash equivalents, and restricted cash	(179)	(42,627)
Cash, cash equivalents, and restricted cash – beginning of period	19,473	69,870
Effects of currency translation on cash, cash equivalents, and restricted cash	(28)	(176)
Cash, cash equivalents, and restricted cash – end of period	19,266	27,067
Non-cash investing and financing activities
Purchase of property and equipment not yet paid	4,064	1,661
Assets acquired under operating leases	(880)	243
Assets acquired under financing leases	1,682	0
Unrealized gains and losses on currency translation	(11)	0
Unrealized gains and losses on available-for-sale securities	(44)	75
Cashless issuance of SciSafe earnout shares	2,263	817
Supplemental Cash Flow Information [Abstract]
Cash interest paid	1,394	230
Returned shares from settlement of Global Cooling escrow	$ (5,115)	$ 0